ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2026
Interplay between Genetic Ancestry, Self-reported Race and Ethnicity, and Clinical Factors in Pediatric Acute Lymphoblastic Leukemia: A REDIAL Consortium Report.
Pragati Kore, Jennifer M Geris, Maria Leon-Camarena, Maria I Castellanos, Olga A Taylor, Veronica Garcia-Morales, Austin L Brown, Pagna Sok, Jeremy M Schraw, Van Huynh and 14 more
Abstract read
In one paragraphArticle in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
24 authors.
Pragati Kore *Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.ORCID 0000-0003-1877-5819 Maria I CastellanosDepartment of Pediatrics, Division of Pediatric Oncology, University of California San Francisco, San Francisco, California.ORCID 0000-0002-6464-1056 Olga A TaylorDepartment of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-5801-8639 Veronica Garcia-MoralesDepartment of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas.ORCID 0009-0007-4650-5345 Austin L BrownDepartment of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas.ORCID 0000-0001-5802-5073 Pagna SokDepartment of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas.ORCID 0000-0001-8210-4580 Jeremy M SchrawDepartment of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-6674-9562 Kathleen F LudwigDepartment of Pediatrics, University of Texas Southwestern Medical Center/Children's Health, Dallas, Texas.ORCID 0009-0005-4791-2749 Laura J KlesseDepartment of Pediatrics, University of Texas Southwestern Medical Center/Children's Health, Dallas, Texas.ORCID 0000-0003-1323-7720 Sandi L PruittDepartment of Pediatrics, University of Texas Southwestern Medical Center/Children's Health, Dallas, Texas.ORCID 0000-0002-1007-9176 Amy E HughesDepartment of Pediatrics, University of Texas Southwestern Medical Center/Children's Health, Dallas, Texas.ORCID 0000-0002-1085-0282 Kevin TienDepartment of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas.ORCID 0009-0005-8449-446X Timothy GriffinDepartment of Hematology-Oncology, The Children's Hospital of San Antonio, Baylor College of Medicine, San Antonio, Texas.ORCID 0009-0007-9987-4427 Rodrigo EranaDepartment of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas.ORCID 0009-0001-9218-645X Juan Carlos BerniniDepartment of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas.ORCID 0009-0004-8301-9811 Maria M GramatgesDepartment of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-0947-104X Elizabeth G AtkinsonDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-6308-776X Philip J Lupo *Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas.ORCID 0000-0003-0978-5863 Michael E Scheurer *Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-8379-6088 Karen R Rabin *Department of Pediatrics, Division of Pediatric Oncology, University of California San Francisco, San Francisco, California.ORCID 0000-0002-4081-8195 Funding
Reducing Disparities in Acute Leukemia (REDIAL) Consortium U54CA302464 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Stacey Pereira · 2025 to 2026
$7.2MGenetics & Genomics Training ProgramT32GM139534 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI GAD SHAULSKY · 2021 to 2026
$4.8MImproving Outcome Disparities for Latino Children and Adolescents with Acute Lymphoblastic LeukemiaP20CA262733 · NCI · BAYLOR COLLEGE OF MEDICINE · PI GRAMATGES, MARIA MONICA · 2021 to 2023
$3.2MEmpowering gene discovery and accelerating clinical translation for diverse admixed populationsR01HG012869 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI Elizabeth Grace Atkinson · 2023 to 2026
$3.1MThe Clinical Translational Research Certificate of Added Qualification ProgramT32GM136554 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI Melissa Suter, IGNATIA B VAN DEN VEYVER · 2020 to 2026
$3.0MCancer Prevention and Research Institute of Texas (CPRIT) RP160771Cancer Prevention and Research Institute of Texas (CPRIT) RP210037Cancer Prevention and Research Institute of Texas (CPRIT) RP210064Cancer Prevention and Research Institute of Texas (CPRIT) RP210075National Cancer Institute (NCI) P20CA262733National Institutes of Health (NIH) R01HG012869National Institutes of Health (NIH) T32 GM139534-02/GM136554-05NCI NIH HHS P20 CA262733NCI NIH HHS U54 CA302464NHGRI NIH HHS R01 HG012869NIGMS NIH HHS T32 GM136554NIGMS NIH HHS T32 GM139534St. Baldrick's Foundation (SBF) 522277
6 · The paper itselfAbstract
backgroundPediatric acute lymphoblastic leukemia (ALL) is the most common cancer in children, and its incidence and outcomes vary by race and ethnicity.
methodsThe Reducing Ethnic Disparities in Acute Leukemia (REDIAL) Consortium has assembled a cohort of patients <25 years at diagnosis to examine genetic and neighborhood-level factors influencing ALL. As the cohort is ongoing, for this report, we examined sociodemographic and cytogenetic factors that might be associated with ALL outcome disparities.
resultsAmong 2,512 patients diagnosed between 2005 and 2020, we observed distinct patterns of genetic ancestry and residential characteristics across self-reported race and ethnicity. Latino children, who comprised 55.3% of the cohort, had a mean Amerindigenous ancestry proportion of 50.9%, whereas non-Latino White children exhibited a predominantly European ancestry (mean = 78%). Neighborhood-level analysis revealed significant socioeconomic and geographic differences by race/ethnicity, with Latino children more frequently residing in Latino enclaves or economically disadvantaged neighborhoods. Cytogenetic profiling of 551 patients showed that favorable subtypes (double trisomies and ETV6::RUNX1) predominated overall, but ETV6::RUNX1 was significantly less common in Latino than in non-Latino White children; conversely, CRLF2 overexpression and immunoglobulin heavy chain (IGH) rearrangements were more frequent among Latino children.
conclusionsThis first REDIAL cohort analysis reveals how genetic ancestry and neighborhood-level factors jointly shape the distribution of ALL cytogenetic subtypes, advancing our understanding of contributors to disparities in ALL outcomes. IMPACT: This analysis offers insights into factors underlying disparities in ALL outcomes that may be targeted for mitigation, ultimately guiding more equitable approaches to risk stratification and intervention.
Indexed as
EthnicityPrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentChildChild, PreschoolETS Translocation Variant 6 ProteinFemaleHispanic or LatinoHumansInfantMaleSelf ReportWhiteETS Translocation Variant 6 Protein
Identifiers
PMID41697062
PMCPMC13002320
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390